InvestorsHub Logo
Followers 60
Posts 7401
Boards Moderated 0
Alias Born 10/20/2014

Re: BioBS2012 post# 319502

Thursday, 01/14/2021 9:21:35 PM

Thursday, January 14, 2021 9:21:35 PM

Post# of 426578
LOL! Nissen is evil. His unfounded statements will cost very real human
lives. I do wonder what plans AZN has for Epanova if it had actually
worked without the, uhm, crappy side effect? AZN likely considered
buying AMRN before they chose the cheaper company. Weren't they also
behind some underhanded activities to hurt AMRN? Worldwide, with the
bull market intact and the sharp decline in AMRN's value I think there
are around 30 companies around that world that could afford to buy
AMRN. All it might take is the one corporate scientist that understands
what Vascepa is and how it works...they would know its CVD potential
as well as the ways it could be used for a myriad of other indications
from DES to (possibly) COVID-19. If the "understanding" were there,
so would be the interest.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News